Cargando…

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies

Chronic infection with viral hepatitis is a major risk factor for liver injury and hepatocellular carcinoma (HCC). One major contributing factor to the chronicity is the dysfunction of virus-specific T cell immunity. T cells engineered to express virus-specific T cell receptors (TCRs) may be a thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Healy, Katie, Pasetto, Anna, Sobkowiak, Michał J., Soon, Chai Fen, Cornberg, Markus, Aleman, Soo, Sällberg Chen, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349849/ https://www.ncbi.nlm.nih.gov/pubmed/32560123 http://dx.doi.org/10.3390/cells9061471

Ejemplares similares

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
por: Sällberg, Matti, et al.
Publicado: (2020)

Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR redirection
por: Parrot, Tiphaine, et al.
Publicado: (2021)

Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions
por: Healy, Katie, et al.
Publicado: (2021)

Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy
por: Soon, Chai Fen, et al.
Publicado: (2019)

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
por: Cornberg, Markus, et al.
Publicado: (2021)

Tissue‐resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL‐17
por: Sobkowiak, Michał J., et al.
Publicado: (2018)

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products
por: Silva, Daniela Nascimento, et al.
Publicado: (2022)

Persistence of salivary antibody responses after COVID-19 vaccination is associated with oral microbiome variation in both healthy and people living with HIV
por: Ghorbani, Mahin, et al.
Publicado: (2023)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
por: Marjot, Thomas, et al.
Publicado: (2022)

Mucosal-associated invariant T cells and oral microbiome in persistent apical periodontitis
por: Davanian, Haleh, et al.
Publicado: (2019)

Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients
por: Cornberg, Markus, et al.
Publicado: (2021)

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
por: Pasetto, Anna, et al.
Publicado: (2012)

Molecular Mechanism of Chronic Viral and Non-Viral Liver Diseases
por: Kanda, Tatsuo
Publicado: (2023)

Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
por: Eslam, Mohammed, et al.
Publicado: (2015)

Mental Disorders in Chronic Liver Diseases with Viral Etiology
por: GHEORMAN, V.V., et al.
Publicado: (2015)

Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2021)

Correction to: Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys
por: Alkharaan, Hassan, et al.
Publicado: (2022)

Clinical Microbial Identification of Severe Oral Infections by MALDI-TOF Mass Spectrometry in Stockholm County: an 11-Year (2010 to 2020) Epidemiological Investigation
por: Al-Manei, Khaled, et al.
Publicado: (2022)

Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients
por: Lybeck, Charlotte, et al.
Publicado: (2019)

Viral Diseases of the Liver
por: Lalazar, Gadi, et al.
Publicado: (2013)

Diabetes mellitus and renal involvement in chronic viral liver disease
por: Iovanescu, VF, et al.
Publicado: (2015)

Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease
por: Roca Suarez, Armando Andres, et al.
Publicado: (2021)

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing
por: Silva, D.N., et al.
Publicado: (2022)

Diagnostic Usefulness of Real-Time Elastography for Liver Fibrosis in Chronic Viral Hepatitis B and C
por: Kim, Young Woon, et al.
Publicado: (2014)

Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015–2018
por: Healy, Katie, et al.
Publicado: (2022)

Analyses of RBC Insulin Receptor Bindings in Chronic Liver Disease(†)
por: Yoon, Kyung Woo, et al.
Publicado: (1986)

Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis
por: Kimmann, Markus, et al.
Publicado: (2019)

Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
por: Griemsmann, Marie, et al.
Publicado: (2022)

Individual Epitope-Specific CD8(+) T Cell Immune Responses Are Shaped Differently during Chronic Viral Infection
por: Klein, Sebastian, et al.
Publicado: (2023)

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
por: Boettler, Tobias, et al.
Publicado: (2020)

The Nuclear Receptor PXR in Chronic Liver Disease
por: Sayaf, Katia, et al.
Publicado: (2021)

Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
por: Kuriyama, Shoko, et al.
Publicado: (2007)

Viral hepatitis and liver cancer
por: Ringehan, Marc, et al.
Publicado: (2017)

Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load
por: Peleg, Noam, et al.
Publicado: (2019)

The role of HBsAg levels in the current management of chronic HBV infection
por: Höner zu Siederdissen, Christoph, et al.
Publicado: (2014)

Circulating and Salivary Antibodies to Fusobacterium nucleatum Are Associated With Cystic Pancreatic Neoplasm Malignancy
por: Alkharaan, Hassan, et al.
Publicado: (2020)

Pseudorabies Virus Inhibits Expression of Liver X Receptors to Assist Viral Infection
por: Wang, Yi, et al.
Publicado: (2022)

The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

LIVER BIOPSY: IMPORTANCE OF SPECIMEN SIZE IN THE DIAGNOSIS AND STAGING OF CHRONIC VIRAL HEPATITIS
por: CORAL, Gabriela P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n4u00ac94nioaruin3pcl0d3mv